CHRIS BARTY
CO-FOUNDER/CTO
LUMITRON TECHNOLOGIES INC.
WHY: Co-founded Irvine-based developer pioneering an ultra-high-intensity, laser-based X-ray system called HyperVIEW for the next generation of cancer treatments.
IN THE NEWS: Lumitron’s X-ray imaging system granted designation of “Breakthrough Device” from FDA in January for its utilization of the K-Edge subtraction technique to improve contrast-enhanced imaging for detecting breast cancer.
NOTABLE: Professor of physics and astronomy at the University of California, Irvine; previously CTO at the National Ignition Facility Directorate at the Lawrence Livermore National Laboratory, where he spent 17 years inventing the core technologies upon which Lumitron’s system is based.
QUOTABLE: “Lumitron’s HyperVIEW laser-Compton X-ray source is an alternative to traditional X-ray tubes that can provide images with significantly greater clarity and accuracy. These capabilities can both enable more reliable detection and reduce the dose of radiation received by the patient.”
